Right, I think the FDA will reject Affrezza again. No insiders were buying at $2 (except Al converting debt to shares). That told me a lot. Now insiders are dumping hundreds of thousands of shares. Again that tells me much.
I don't think Al has been straight with investors regarding trial data and status of partnerships. Not a single partner has stepped up. Big pharma could have backed up the truck with shares at $2. They didn't.
Where there is smoke there is fire. I think Al's army of retail idiots is going to get burned big time.